cAMP inhibits IGF-I-induced mitogenesis in fetal rat brown adipocytes: role of p21 ras

Exp Cell Res. 1995 May;218(1):305-9. doi: 10.1006/excr.1995.1159.

Abstract

Dibutyryl cAMP (DBcAMP) inhibited insulin-like growth factor I (IGF-I)-induced DNA synthesis of rat fetal brown adipocyte primary cultures. Its mitogenic inhibitory capacity, measured as [3H]thymidine incorporation into acid-precipitable material, was dose-dependent, being maximal at 0.5 mM. The entry of cells into S + G2/M phases of the cell cycle and the increase in cell number induced by IGF-I were partially inhibited by DBcAMP at 24 h and totally prevented at 48 h. DBcAMP inhibited the mRNA expression of c-myc induced by IGF-I at 2 h. Moreover, DBcAMP inhibited in parallel H-ras mRNA expression, p21 ras, and proliferating cellular nuclear antigen protein content induced by IGF-I at 24 and 48 h of culture, respectively, suggesting the involvement of p21 ras in the progression of fetal brown adipocytes through the S phase of the cell cycle and DNA synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology*
  • Adipocytes / cytology
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Adipose Tissue, Brown / cytology
  • Adipose Tissue, Brown / drug effects*
  • Adipose Tissue, Brown / metabolism
  • Animals
  • Bucladesine / pharmacology*
  • Cell Division / drug effects*
  • Cells, Cultured
  • Culture Media, Serum-Free
  • Cyclic AMP / metabolism*
  • Fetus
  • Gene Expression / drug effects
  • Genes, myc
  • Genes, ras
  • Insulin-Like Growth Factor I / pharmacology*
  • Kinetics
  • Proto-Oncogene Proteins c-myc / biosynthesis
  • Proto-Oncogene Proteins p21(ras) / biosynthesis
  • RNA, Messenger / analysis
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar

Substances

  • Culture Media, Serum-Free
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Bucladesine
  • Insulin-Like Growth Factor I
  • Cyclic AMP
  • Proto-Oncogene Proteins p21(ras)
  • 1-Methyl-3-isobutylxanthine